Complex Biologics CDMO+ CRO - Abzena

Awards & Achievements

Celebrating our passion for scientific innovation.

At Abzena, we are proud to have been recognized for our growth and achievements – we could not do those without the support and trust of our customers. Thank you.

Each award and recognition is a testament to our biologic services, our values, our colleagues, and to our dedication of working with our partners and customers.

Abzena wins a 2025 CDMO Leadership Award

Abzena Wins 'Champion Award' at the 2025 CDMO Leadership Awards

Abzena are honored to have been recognized as winner of the ‘Champion Award‘ in the ‘Biologics – Global’ category at the 2025 CDMO Leadership Awards hosted during DCAT Week in New York City. This award recognizes our commitment to quality excellence and moving our customers medicines forward. We are incredibly thankful for our biotech and pharma customers alike who helped us to win this prestigious award.

Abzena wins a 2025 CDMO Leadership Award

Abzena Wins a 2025 CDMO Leadership Award

Abzena has been recognized as a winner of a 2025 CDMO Leadership Award in the “Biologics – Global” category and are a finalist for the Champion Award, recognizing our commitment to excellence in advanced drug development.

Life Science Review - Top Contract Manufacturing Organization 2025 Award - Abzena

Abzena Wins Top Contract Manufacturing Organization 2025 Award from Life Sciences Review

This award is in recognition of Abzena’s stellar reputation and trust among customers and industry peers, evident in the numerous nominations received from subscribers of Life Sciences Review. We are delighted and thankful to have emerged as the ‘Top Contract Manufacturing Organization 2025’ after an exhaustive evaluation by an expert panel of C-level executives, industry thought leaders, and editorial board.

Abzena recognized as Best Novel Treatment Development Partner 2024 by GHP

Abzena was honored to be recognized as the Best Novel Treatment Development Partner 2024 in California by the 2024 Global Excellence Awards.

Abzena Recognized as Top CDMO in 2024 by Pharma Tech Outlook

Abzena was recently named one of the Top 10 Contract Manufacturing Organizations in 2024 for its substantial contributions to the progression of the CDMO sector by Pharma Tech Outlook magazine.

Abzena Recognized as Best Performing R&D Service Provider of the Year by One Nucleus

One Nucleus recognize Abzena as the ‘Best Performing R&D Service Provider of the Year’.

Abzena announced as best CRO at World ADC awards

Abzena were announced as the winner of the Best Contract Research (CRO) category at the World ADC Awards 2020. The World ADC awards recognise innovation, leadership and devotion in the field of Antibody Drug Conjugates (ADCs) and include nine categories designed to acknowledge the extraordinary work and commercial acumen that companies have demonstrated in order to propel these therapeutics to the forefront of cancer research.